Trendingnow
Big Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026

Latest stories from Fortune
More Big TechPage 2 of 73

By Sasha RogelbergAugust 23, 2026

By Julian Hast and BloombergAugust 22, 2026

By Brody Ford, Ian King and BloombergAugust 22, 2026

By Saurabh GuptaAugust 22, 2026

By Shawn TullyAugust 22, 2026

By Jordan BlumAugust 22, 2026

By Sebastian HerreraAugust 21, 2026

By Joshua HongAugust 21, 2026

By Fortune EditorsAugust 21, 2026

By James Pollard and The Associated PressAugust 21, 2026

By Mark MinevichAugust 21, 2026

By Tatiana SatauaAugust 21, 2026

By Orianna Rosa RoyleAugust 21, 2026

By Amanda GerutAugust 20, 2026

By Jesse Bedayn, Marc Levy, Scott Bauer and The Associated PressAugust 20, 2026

By Barbara Ortutay and The Associated PressAugust 20, 2026

By Tatiana SatauaAugust 20, 2026

By Amanda GerutAugust 20, 2026

By Sasha RogelbergAugust 20, 2026

By Sebastian HerreraAugust 19, 2026

By Barbara Ortutay, Kaitlyn Huamani and The Associated PressAugust 19, 2026

By The Associated Press and Kaitlyn HuamaniAugust 19, 2026

By Sarah GlodekAugust 19, 2026

By Josh Funk and The Associated PressAugust 19, 2026

By Lily Mae LazarusAugust 19, 2026

By Sheryl EstradaAugust 19, 2026

By Tatiana SatauaAugust 19, 2026
Most Popular
















